ArticleContemporary clinical trials2025
Dismantling open-label placebos and their rationales: A remote 4-arm randomized controlled trial protocol.
Article in Contemporary clinical trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Open-label placebos for low back pain: unresolved challenges and next steps.Pain management · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo explore the effect of rationales on placebos described honestly as inactive pills, (open-label placebos; OLPs) on chronic pain.
designDismantling 4-arm randomized controlled trial.
settingRemote study with United-States residents. SUBJECTS: Chronic pain patients aged 18 to 89.
methodsWe plan to recruit 340 subjects, randomized before consent (Zelen randomization procedure) into one of 4 groups. Participants in a no-treatment group will not receive any OLPs. Participants in the three OLP groups will be told to take an OLP pill twice daily for 21 days. The information participants are given about placebos will vary. Those in the "Standard-OLP" group will be provided with a rationale similar to those used in prior OLP trials. Those in the "Mindfulness-OLP" group will be provided with a rationale taking a mindfulness approach. Those in the "Control-OLP" group (and no-treatment group) will be provided with length-matched information about pain demographics; no placebo information will be given. This dismantling design will allow us to compare rationales (Standard-OLP vs Mindfulness-OLP), and examine the rationale effect (Standard-OLP or Mindfulness-OLP vs. Control-OLP), the placebo effect (Standard-OLP or Mindfulness-OLP vs. No-treatment), and the pill effect (Control-OLP vs no-treatment). Pain intensity over 42 days is the primary outcome.
conclusionsThis trial will investigate how different components of OLPs impact pain among a chronic pain population. We also highlight novel ways to address limitations of prior OLP studies; namely, lack of blinding and improper controls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.